Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review

BACKGROUND: AML is a rapidly progressing bone marrow cancer, with poor survival rates compared to other types of leukemia. IC and NIC as well as BSC treatment options are available; however, there is scant published literature on the impact of disease and treatment on the HRQoL in patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsythe, Anna, Kwon, Christina S, Bell, Timothy, Smith, T Alexander, Arondekar, Bhakti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336133/
https://www.ncbi.nlm.nih.gov/pubmed/30679915
http://dx.doi.org/10.2147/CEOR.S187409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336133/
https://www.ncbi.nlm.nih.gov/pubmed/30679915
http://dx.doi.org/10.2147/CEOR.S187409

Ejemplares similares